[1]
Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. The Journal of infectious diseases. 1980 May:141(5):590-602
[PubMed PMID: 6989929]
[2]
Polson AG, Bass BL, Casey JL. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature. 1996 Apr 4:380(6573):454-6
[PubMed PMID: 8602246]
Level 3 (low-level) evidence
[3]
Kiesslich D, Crispim MA, Santos C, Ferreira Fde L, Fraiji NA, Komninakis SV, Diaz RS. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus. The Journal of infectious diseases. 2009 Jun 1:199(11):1608-11. doi: 10.1086/598955. Epub
[PubMed PMID: 19388852]
[4]
Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR. Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 Aug 1:69(4):709-712. doi: 10.1093/cid/ciz001. Epub
[PubMed PMID: 30605508]
[5]
Liaw YF, Chiu KW, Chu CM, Sheen IS, Huang MJ. Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. The Journal of infectious diseases. 1990 Nov:162(5):1170-2
[PubMed PMID: 2121838]
[6]
Weisfuse IB, Hadler SC, Fields HA, Alter MJ, O'Malley PM, Judson FN, Ostrow DG, Altman NL. Delta hepatitis in homosexual men in the United States. Hepatology (Baltimore, Md.). 1989 Jun:9(6):872-4
[PubMed PMID: 2714738]
[7]
Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology (Baltimore, Md.). 2000 Oct:32(4 Pt 1):824-7
[PubMed PMID: 11003629]
Level 2 (mid-level) evidence
[8]
Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nature reviews. Gastroenterology & hepatology. 2010 Jan:7(1):31-40. doi: 10.1038/nrgastro.2009.205. Epub
[PubMed PMID: 20051970]
[9]
Negro F, Korba BE, Forzani B, Baroudy BM, Brown TL, Gerin JL, Ponzetto A. Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks. Journal of virology. 1989 Apr:63(4):1612-8
[PubMed PMID: 2926865]
[10]
Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology. 2014 Apr:146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19
[PubMed PMID: 24361467]
[11]
Smedile A, Farci P, Verme G, Caredda F, Cargnel A, Caporaso N, Dentico P, Trepo C, Opolon P, Gimson A, Vergani D, Williams R, Rizzetto M. Influence of delta infection on severity of hepatitis B. Lancet (London, England). 1982 Oct 30:2(8305):945-7
[PubMed PMID: 6127458]
[12]
Smedile A, Dentico P, Zanetti A, Sagnelli E, Nordenfelt E, Actis GC, Rizzetto M. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology. 1981 Dec:81(6):992-7
[PubMed PMID: 7286594]
[13]
Bichko V, Netter HJ, Wu TT, Taylor J. Pathogenesis associated with replication of hepatitis delta virus. Infectious agents and disease. 1994 Apr-Jun:3(2-3):94-7
[PubMed PMID: 7812659]
[14]
Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, Ronchi G, Colombo M. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009 May:136(5):1629-38. doi: 10.1053/j.gastro.2009.01.052. Epub 2009 Jan 29
[PubMed PMID: 19208358]
[15]
Niro GA, Smedile A, Andriulli A, Rizzetto M, Gerin JL, Casey JL. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology (Baltimore, Md.). 1997 Mar:25(3):728-34
[PubMed PMID: 9049226]
Level 3 (low-level) evidence
[16]
Wu JC, Choo KB, Chen CM, Chen TZ, Huo TI, Lee SD. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet (London, England). 1995 Oct 7:346(8980):939-41
[PubMed PMID: 7564729]
[17]
Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL. A genotype of hepatitis D virus that occurs in northern South America. Proceedings of the National Academy of Sciences of the United States of America. 1993 Oct 1:90(19):9016-20
[PubMed PMID: 8415646]
Level 3 (low-level) evidence
[18]
Aragona M, Macagno S, Caredda F, Crivelli O, Lavarini C, Maran E, Farci P, Purcell RH, Rizzetto M. Serological response to the hepatitis delta virus in hepatitis D. Lancet (London, England). 1987 Feb 28:1(8531):478-80
[PubMed PMID: 2881041]
[19]
Shattock AG, Morgan BM. Sensitive enzyme immunoassay for the detection of delta antigen and anti-delta, using serum as the delta antigen source. Journal of medical virology. 1984:13(1):73-82
[PubMed PMID: 6363622]
[20]
Buti M, Esteban R, Jardí R, Esteban JI, Guardia J. Serological diagnosis of acute delta hepatitis. Journal of medical virology. 1986 Jan:18(1):81-5
[PubMed PMID: 3944592]
[21]
Bonino F, Heermann KH, Rizzetto M, Gerlich WH. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. Journal of virology. 1986 Jun:58(3):945-50
[PubMed PMID: 3701932]
[22]
Buti M, Esteban R, Jardi R, Rodriguez-Frias F, Casacuberta J, Esteban JI, Allende E, Guardia J. Chronic delta hepatitis: detection of hepatitis delta virus antigen in serum by immunoblot and correlation with other markers of delta viral replication. Hepatology (Baltimore, Md.). 1989 Dec:10(6):907-10
[PubMed PMID: 2583685]
[23]
Dinolfo L, Abate ML, Bertolo P, Bosio P, Rosina F, Cavicchini A, Rizzetto M, Negro F. Detection of hepatitis D virus RNA in serum by a reverse transcription, polymerase chain reaction-based assay. International journal of clinical & laboratory research. 1995:25(1):35-9
[PubMed PMID: 7787208]
[24]
Mederacke I, Bremer B, Heidrich B, Kirschner J, Deterding K, Bock T, Wursthorn K, Manns MP, Wedemeyer H. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. Journal of clinical microbiology. 2010 Jun:48(6):2022-9. doi: 10.1128/JCM.00084-10. Epub 2010 Mar 29
[PubMed PMID: 20351206]
[25]
Abbas Z, Khan MA, Salih M, Jafri W. Interferon alpha for chronic hepatitis D. The Cochrane database of systematic reviews. 2011 Dec 7:2011(12):CD006002. doi: 10.1002/14651858.CD006002.pub2. Epub 2011 Dec 7
[PubMed PMID: 22161394]
Level 1 (high-level) evidence
[26]
Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology (Baltimore, Md.). 2018 Apr:67(4):1560-1599. doi: 10.1002/hep.29800. Epub
[PubMed PMID: 29405329]